| eXmoor Pharma Concepts Ltd.. (5/30/23). "Press Release: eXmoor Pharma Completes $35 Million Series A to Expand Cell and Gene Therapy Manufacturing Capabilities". Bristol. |
2023-05-30 |
| ElevateBio, LLC. (5/24/23). "Press Release: ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth". Waltham, MA. |
2023-05-24 |
| Renegade Therapeutics, Inc.. (5/23/23). "Press Release: ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine". Cambridge, MA. |
2023-05-23 |
| Council of European BioRegions (CEBR). (5/17/23). "Press Release: CEBR Appoints New President and Vice-President at Its Annual Meeting 2023". Stuttgart. |
2023-05-17 |
| Closed Loop Medicine Ltd.. (5/17/23). "Press Release: Closed Loop Medicine and Pharmanovia Enter a Co-development Partnership for Precision Medicine Combination Therapeutics". London & Basildon. |
2023-05-17 |
| H.E.L. Group. (5/16/23). "Press Release: H.E.L Group Makes Senior Appointments as It Continues to Scale Globally". London. |
2023-05-16 |
| Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent. |
2023-05-15 |
| Evonetix Ltd.. (5/15/23). "Press Release: Evonetix Delivers First Chip-synthesized DNA to the University of Cambridge". |
2023-05-15 |
| Uniqure N.V.. (5/15/23). "Press Release: Uniqure Announces Sale of Royalty Interest in Hemgenix for up to $400 Million". Lexington, MA & Amsterdam. |
2023-05-15 |
| Nido Biosciences, Inc.. (5/15/23). "Press Release: Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases". Watertown, MA. |
2023-05-15 |
| Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg. |
2023-05-12 |
| Bicycle Therapeutics plc. (5/1023). "Press Release: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology". Berlin, Cambridge & Boston, MA. |
2023-05-10 |
| Ascend Gene and Cell Therapies Ltd.. (5/9/23). "Press Release: Gene and Cell Therapy Manufacturing Specialist Ascend Launches with over $130M of Funding as Expert Teams Merge". London. |
2023-05-09 |
| Bruker Corporation. (5/8/23). "Press Release: Bruker Announces Acquisition of Zontal to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions". Billerica, MA. |
2023-05-08 |
| Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg. |
2023-05-05 |
| Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan. |
2023-05-05 |
| MicrofluidX Ltd.. (5/2/23). "Press Release: MicrofluidX and Immatics Working Together on Automated End-to-End Bioprocessing for TCR-T Therapies". Stevenage & Houston, TX. |
2023-05-02 |
| Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA. |
2023-04-26 |
| Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin. |
2023-04-18 |
| Complement Therapeutics GmbH. (4/17/23). "Press Release: Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases". Munich. |
2023-04-17 |
| Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. |
2023-04-13 |
| Vitarka Therapeutics Ltd.. (4/6/23). "Press Release: UK Biotech Start-up Secures £1.27M to Revolutionise Intracellular Drug Delivery through Tumour Targeted Technology". |
2023-04-06 |
| Syncona Ltd.. (4/5/23). "Press Release: Syncona Appoints Roel Bulthuis as Managing Partner". |
2023-04-05 |
| AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich. |
2023-04-04 |
| Mosaic Therapeutics Ltd.. (4/4/23). "Press Release: Mosaic Therapeutics Closes $28m Series A Funding and Appoints Brian Gladsden as CEO". Cambridge. |
2023-04-04 |
| Biocartis Group N.V.. (4/4/23). "Press Release: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla Platform". Mechelen. |
2023-04-04 |
| Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen. |
2023-04-04 |
| Endpoints Company. (4/3/23). "Press Release: Financial Times Acquires Majority Stake in Endpoints News". Lawrence, KS. |
2023-04-03 |
| Sofinnova Partners. (3/28/23). "Press Release: BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures to Unlock Drug-bacteria Interactions". London. |
2023-03-28 |
| SR One Capital Management. (3/27/23). "Press Release: SR One Closes Second Venture Fund at $600M". Redwood City, CA & London. |
2023-03-27 |
| Macomics Ltd.. (3/23/23). "Press Release: Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy". |
2023-03-23 |
| Aldena Therapeutics Inc.. (3/16/23). "Press Release: Aldena Therapeutics Accelerates Its Novel and Disruptive Approach to Immuno-Dermatology". Boston, MA. |
2023-03-16 |
| Owlstone Medical Ltd.. (3/15/23). "Press Release: Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection". Cambridge. |
2023-03-15 |
| MorphoSys AG. (3/14/23). "Press Release: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer". Planegg. |
2023-03-14 |
| CN Bio Innovations Ltd.. (3/14/23). "Press Release: CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing". Cambridge. |
2023-03-14 |
| Teitur Trophics ApS. (3/14/23). "Press Release: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases". Aarhus. |
2023-03-14 |
| Exscientia plc. (3/14/23). "Press Release: Exscientia Announces Expansion of its Precision Oncology Pipeline". Oxford. |
2023-03-14 |
| UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels. |
2023-03-09 |
| UCB S.A.. (3/9/23). "Press Release: Cancer Research UK Signs Multi-Project Collaboration with UCB to Advance Oncology Antibody Candidates". Brussels & London. |
2023-03-09 |
| Personalis, Inc.. (3/7/23). "Press Release: Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay". Fremont, CA. |
2023-03-07 |
| Exscientia plc. (3/7/23). "Press Release: Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform". Oxford & Berlin. |
2023-03-07 |
| Adaptimmune Therapeutics plc. (3/6/23). "Press Release: Adaptimmune and TCR2 Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors". Philadeliphia, PA, Oxford & Canbridge, MA. |
2023-03-06 |
| Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug. |
2023-03-03 |
| MorphoSys AG. (3/2/23). "Press Release: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs". Planegg. |
2023-03-02 |
| Antiverse Ltd.. (3/1/23). "Press Release: Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery platform". Cardiff. |
2023-03-01 |
| Five Alarm Bio Ltd.. (2/27/23). "Press Release: Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment". Cambridge. |
2023-02-27 |
| AdBio Partners S.A.S.. (2/23/23). "Press Release: AdBio Partners Appoints Geoffroy de Ribains as Managing Partner". Paris. |
2023-02-23 |
| Cerevance. (2/23/23). "Press Release: Cerevance Expands Series B Financing with Additional $51 Million". Boston, MA. |
2023-02-23 |
| eXmoor Pharma Concepts Ltd.. (2/22/23). "Press Release: eXmoor Pharma and Vaccine Developer Imophoron Sign Process Development Partnership". Bristol. |
2023-02-22 |
| Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London. |
2023-02-20 |
| High-Tech Gründerfonds Management GmbH. (2/17/23). "Press Release: Selfapy Brings a Strategic Investor on Board". Berlin. |
2023-02-17 |
| Targovax ASA. (2/16/23). "Press Release: Targovax Announces Financing of up to NOK 300m Over Three Years to Advance Its Clinical Cancer Programs and Pre-clinical Circular RNA platform". Oslo. |
2023-02-16 |
| Lift BioSciences Ltd.. (2/16/23). "Press Release: LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership". London & Munich. |
2023-02-16 |
| Panekès Partners SGR S.p.A.. (2/16/23). "Press Release: Panakès Partners Announces the Final Closing of the »Purple« Fund at 175 Million Euros". Milan. |
2023-02-16 |
| Maxion Therapeutics Ltd.. (2/15/23). "Press Release: Maxion Therapeutics’ $16 Million Series A to Drive Antibody Development for Previously Untreatable Ion Channel and GPCR-driven Diseases". Cambridge. |
2023-02-15 |
| Biotage AB. (2/15/23). "Press Release: Biotage Strengthens Its Position as a Global Chromatography Leader with the Transformative Acquisition of Astrea Bioseparations". Uppsala. |
2023-02-15 |
| Charles River Laboratories International, Inc.. (2/15/23). "Press Release: Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration". Wilmington, MA. |
2023-02-15 |
| Replay Holdings LLC. (2/14/23). "Press Release: KKR-backed Replay and MD Anderson Form New Product Company Syena to Pioneer First-in-class TCR-NK Cell Therapy". San Diego, CA, London & Houston, TX. |
2023-02-14 |
| Cydar Ltd.. (2/13/23). "Press Release: Cydar Medical Raises $11.5M (£9.3M) in Series A Funding Round". Cambridge. |
2023-02-13 |
| Bayer AG. (2/13/23). "Press Release: Bayer Completes Acquisition of Blackford Analysis Ltd. [not intended for U.S. and UK Media]". Berlin. |
2023-02-13 |
| Freeline Therapeutics Holdings plc. (2/10/23). "Press Release: Freeline Announces Closing of Sale of Its CMC-focused German Subsidiary". London. |
2023-02-10 |
| BrainRepair UG. (2/8/23). "Press Release: Breakthrough – EUR 50 Million Investment for Start-up BrainRepair UG". Bochum. |
2023-02-08 |
| H.E.L. Group. (2/8/23). "Press Release: H.E.L Group appoints Allen Wang as General Manager of H.E.L China". London. |
2023-02-08 |
| Evonetix Ltd.. (2/7/23). "Press Release: Evonetix Closes $24 Million USD (£20 Million) Financing. Oversubscribed Round Led by Foresite Capital". Cambridge. |
2023-02-07 |
| Oxford Science Enterprises plc. (2/7/23). "Press Release: Oxford Science Enterprises Strengthens Life Sciences Investment Team with Appointment of Sanne de Jongh as Partner". Oxford. |
2023-02-07 |
| APIS Assay Technologies Ltd.. (2/2/23). "Press Release: Clickmer Systems Receives €1.1m Grant to Deliver Innovative Diagnostic Platform for Fast Pandemic Responsiveness". |
2023-02-02 |
| Patient Square Capital L.P.. (2/1/23). "Press Release: Patient Square Capital Announces Record $3.9 Billion Inaugural Fund". Menlo Park, CA. |
2023-02-01 |
| Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm. |
2023-01-30 |
| BioIndustry Assocation (BIA). (1/25/23). "Press Release: BIA Announces New Appointments to the BIA Board". |
2023-01-25 |
| DeuterOncology N.V.. (1/19/23). "Press Release: DeuterOncology Closes €5.65M Series A Financing Round". Liège. |
2023-01-19 |
| Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [not intended for U.S. and UK Media]". Berlin. |
2023-01-18 |
| Green Bioactives Ltd.. (1/17/23). "Press Release: Green Bioactives Appoints Experienced Biotech Leaders Chris Meaney and Andy Hall-Ponselé to Expand Senior Management Team". Edinburgh. |
2023-01-17 |
| BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. |
2023-01-17 |
| Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. |
2023-01-17 |
| Vésale Bioscience. (1/17/22). "Press Release: Vésale Bioscience Receives €1.8M Grant from European Innovation Council for PhageDiag Project". Namur. |
2023-01-17 |
| AstraZeneca plc. (1/16/23). "Press Release: Acquisition of Neogene Therapeutics Completed". |
2023-01-16 |
| BioNTech SE. (1/10/23). "Press Release: BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development". Mainz & London. |
2023-01-10 |
| Astrea Bioseparations. (1/9/23). "Press Release: Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing". |
2023-01-09 |
| Proteros Biostructures GmbH. (1/9/23). "Press Release: Proteros Receives Minority Investment from Private Equity Firm Inflexion". Martinsried. |
2023-01-09 |
| AstraZeneca plc. (1/9/23). "Press Release: AstraZeneca to Acquire CinCor Pharma to Strengthen Cardiorenal Pipeline". |
2023-01-09 |
| Chiesi Farmaceutici S.p.A.. (1/8/23). "Press Release: Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc". Parma, Boston, MA & Dublin. |
2023-01-08 |
| CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. |
2023-01-06 |
| BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz. |
2023-01-06 |
| Akamis Bio Ltd.. (1/5/23). "Press Release: Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics". Cambridge, MA & Oxford. |
2023-01-05 |
| Actimed Therapeutics Ltd.. (1/4/23). "Press Release: Actimed Therapeutics Successfully Closes Second Tranche of £10m Seed Financing". London. |
2023-01-04 |
| Stablepharma Ltd.. (12/23/22). "Press Release: Stablepharma Closed Series A Funding round of $6.4m to Progress Fridge-free Vaccines and mRNA/LNP Stabilisation Technologies". |
2022-12-23 |
| Oxford Biomedica plc. (12/22/22). "Press Release: Oxford Biomedica to Present at 41st Annual J.P. Morgan Healthcare Conference". Seattle, WA. |
2022-12-22 |
| Stifel Financial Corporation. (12/22/22). "Press Release: Stifel to Acquire Torreya Partners". St. Louis, MO. |
2022-12-22 |
| Merck & Co., Inc.. (12/21/22). "Press Release: Lynparza (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone Approved in the EU as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer". Rahway, NJ. |
2022-12-21 |
| Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich. |
2022-12-21 |
| CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. |
2022-12-19 |
| Lift BioSciences Ltd.. (12/19/22). "Press Release: Lift BioSciences Investors Increase Investment in Lift and Johnson and Johnson Welcomes Lift into JLABS". London. |
2022-12-19 |
| Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
| Ori Biotech Ltd.. (12/15/22). "Press Release: Ori Biotech and Inceptor Bio Partner to Accelerate Solid Tumor Cell Therapy Access". London & Morrisville, NC. |
2022-12-15 |
| PhoreMost Ltd.. (12/14/22). "Press Release: PhoreMost and ThinkCyte Collaborate to Advance AI Based Drug Discovery". Cambridge. |
2022-12-14 |
| PrecisionLife Ltd.. (12/14/22). "Press Release: PrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceutical". Oxford. |
2022-12-14 |
| Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. |
2022-12-14 |
| Oxford Biomedica plc. (12/14/22). "Press Release: Oxford Biomedica Solutions Forms New Partnerships with Three Biotechnology Companies". Oxford. |
2022-12-14 |
| BehaVR, Inc.. (12/13/22). "Press Release: BehaVR and OxfordVR Combine and Raise Series B to Create Largest VR Delivery Platform for Evidence-Based Digital Therapeutics". Nashville, TN & Oxford. |
2022-12-13 |
| Green Bioactives Ltd.. (12/13/22). "Press Release: Green Bioactives Completes £2.6m Seed Financing to Advance Its Sustainable Plant Products Biomanufacturing Platform". Edinburgh. |
2022-12-13 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
